Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon

Detalhes bibliográficos
Autor(a) principal: Rafael-Heredia, Arturo
Data de Publicação: 2022
Outros Autores: Iglesias-Osores, Sebastian, Saavedra-Camacho, Johnny Leandro, Bocanegra-Mozombite, Jesica Julissa, Leveau-Bartra, Walter Román, Leveau-Bartra, Orison Armando, Córdova-Rojas, Lizbeth M.
Tipo de documento: preprint
Idioma: spa
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/3828
Resumo: Objectives: The objective of this research was to describe the prevalence of antibodies to COVID19 in a prison in Ucayali, Peru. Methods: 325 inmates were selected from the Penitentiary Centerin Pucallpa, Peru through simple random sampling. On 06/25/20 and 07/24/20, the fingerpuncture samples were taken from the inmates for COVID-19, the blood sample was obtainedfor the chemo-luminescent microparticle immunoassay tests. Descriptive statistics were usedfor data analysis with InfoStat software. Results: Of the 325 inmates evaluated, 80 were women(25%) and 245 men (75%), the mean age was 43 years (SD 12.44). Regarding the serologicalresults, 137 (42%) were found with positive IgG and 188 (58%) negative IgG. Regarding positiveIgM 145 (45%) and negative IgM 180 (55%). Regarding the distribution of positive cases by sex,we have 47 women and 141 men with a positive result for IgM or IgG. Conclusion: It is concludedthat there is a high number of inmates who have antibodies against COVID-19.
id SCI-1_bb68f824dce708a5d44049993df7dbc3
oai_identifier_str oai:ops.preprints.scielo.org:preprint/3828
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian AmazonPrevalencia serológica de anticuerpos al SARS-CoV-2 en una prisión de la amazonia del PerúUses of EpidemiologyCOVID-19SARS-CoV-2prisonsPeruUsos de la EpidemiologíaCOVID-19SARS-CoV-2prisionesPerúObjectives: The objective of this research was to describe the prevalence of antibodies to COVID19 in a prison in Ucayali, Peru. Methods: 325 inmates were selected from the Penitentiary Centerin Pucallpa, Peru through simple random sampling. On 06/25/20 and 07/24/20, the fingerpuncture samples were taken from the inmates for COVID-19, the blood sample was obtainedfor the chemo-luminescent microparticle immunoassay tests. Descriptive statistics were usedfor data analysis with InfoStat software. Results: Of the 325 inmates evaluated, 80 were women(25%) and 245 men (75%), the mean age was 43 years (SD 12.44). Regarding the serologicalresults, 137 (42%) were found with positive IgG and 188 (58%) negative IgG. Regarding positiveIgM 145 (45%) and negative IgM 180 (55%). Regarding the distribution of positive cases by sex,we have 47 women and 141 men with a positive result for IgM or IgG. Conclusion: It is concludedthat there is a high number of inmates who have antibodies against COVID-19.Objetivos: El objetivo de esta investigación fue el de describir la prevalencia de anticuerpos para COVID-19 en una cárcel de Ucayali, Perú. Métodos: Se seleccionaron 325 reclusos del Centro penitenciario en Pucallpa, Perú mediante un muestreo aleatorio simple. Del 25/06/20 y el 24/07/20 se tomaron las muestras punción dactilar de los reclusos para COVID-19, se obtuvo la muestra de sangre para las pruebas de inmunoensayo de micropartículas quimio luminiscentes. Se utilizó estadística descriptiva para en análisis de los datos con el software InfoStat. Resultados: De los 325 reclusos evaluados 80 eran mujeres (25%) y 245 varones (75%), la media de la edad fue de 43 años (DE 12,44). En cuantos a los resultados serológicos se encontraron a con IgG positivo a 137 (42%) e IgG negativo 188 (58%). En cuanto a IgM positivo 145 (45%) e IgM negativo 180 (55%). En cuanto a la distribución de casos positivos por sexo contamos con 47 mujeres y 141 varones con resultado positivo para IgM o IgG. Conclusión: Se concluye con que existe un elevado número de reclusos que tienen anticuerpos contra la COVID-19.SciELO PreprintsSciELO PreprintsSciELO Preprints2022-03-25info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/382810.1590/SciELOPreprints.3828spahttps://preprints.scielo.org/index.php/scielo/article/view/3828/7123Copyright (c) 2022 Arturo Rafael-Heredia, Sebastian Iglesias-Osores, Johnny Leandro Saavedra-Camacho, Jesica Julissa Bocanegra-Mozombite, Walter Román Leveau-Bartra, Orison Armando Leveau-Bartra, Lizbeth M. Córdova-Rojashttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRafael-Heredia, ArturoIglesias-Osores, SebastianSaavedra-Camacho, Johnny LeandroBocanegra-Mozombite, Jesica JulissaLeveau-Bartra, Walter RománLeveau-Bartra, Orison ArmandoCórdova-Rojas, Lizbeth M.reponame:SciELO Preprintsinstname:SciELOinstacron:SCI2022-03-23T01:57:48Zoai:ops.preprints.scielo.org:preprint/3828Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2022-03-23T01:57:48SciELO Preprints - SciELOfalse
dc.title.none.fl_str_mv Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
Prevalencia serológica de anticuerpos al SARS-CoV-2 en una prisión de la amazonia del Perú
title Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
spellingShingle Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
Rafael-Heredia, Arturo
Uses of Epidemiology
COVID-19
SARS-CoV-2
prisons
Peru
Usos de la Epidemiología
COVID-19
SARS-CoV-2
prisiones
Perú
title_short Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
title_full Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
title_fullStr Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
title_full_unstemmed Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
title_sort Serological prevalence of antibodies to SARS-CoV-2 in a prison in the Peruvian Amazon
author Rafael-Heredia, Arturo
author_facet Rafael-Heredia, Arturo
Iglesias-Osores, Sebastian
Saavedra-Camacho, Johnny Leandro
Bocanegra-Mozombite, Jesica Julissa
Leveau-Bartra, Walter Román
Leveau-Bartra, Orison Armando
Córdova-Rojas, Lizbeth M.
author_role author
author2 Iglesias-Osores, Sebastian
Saavedra-Camacho, Johnny Leandro
Bocanegra-Mozombite, Jesica Julissa
Leveau-Bartra, Walter Román
Leveau-Bartra, Orison Armando
Córdova-Rojas, Lizbeth M.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rafael-Heredia, Arturo
Iglesias-Osores, Sebastian
Saavedra-Camacho, Johnny Leandro
Bocanegra-Mozombite, Jesica Julissa
Leveau-Bartra, Walter Román
Leveau-Bartra, Orison Armando
Córdova-Rojas, Lizbeth M.
dc.subject.por.fl_str_mv Uses of Epidemiology
COVID-19
SARS-CoV-2
prisons
Peru
Usos de la Epidemiología
COVID-19
SARS-CoV-2
prisiones
Perú
topic Uses of Epidemiology
COVID-19
SARS-CoV-2
prisons
Peru
Usos de la Epidemiología
COVID-19
SARS-CoV-2
prisiones
Perú
description Objectives: The objective of this research was to describe the prevalence of antibodies to COVID19 in a prison in Ucayali, Peru. Methods: 325 inmates were selected from the Penitentiary Centerin Pucallpa, Peru through simple random sampling. On 06/25/20 and 07/24/20, the fingerpuncture samples were taken from the inmates for COVID-19, the blood sample was obtainedfor the chemo-luminescent microparticle immunoassay tests. Descriptive statistics were usedfor data analysis with InfoStat software. Results: Of the 325 inmates evaluated, 80 were women(25%) and 245 men (75%), the mean age was 43 years (SD 12.44). Regarding the serologicalresults, 137 (42%) were found with positive IgG and 188 (58%) negative IgG. Regarding positiveIgM 145 (45%) and negative IgM 180 (55%). Regarding the distribution of positive cases by sex,we have 47 women and 141 men with a positive result for IgM or IgG. Conclusion: It is concludedthat there is a high number of inmates who have antibodies against COVID-19.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-25
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/3828
10.1590/SciELOPreprints.3828
url https://preprints.scielo.org/index.php/scielo/preprint/view/3828
identifier_str_mv 10.1590/SciELOPreprints.3828
dc.language.iso.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/3828/7123
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:SciELO
instacron:SCI
instname_str SciELO
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - SciELO
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047827882311680

Registros relacionados